Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool
April 1, 2022 | NHS, Promotion, healthcare
Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.
Wilmington Healthcare, which provides data, insight and intelligence for pharmaceutical, life sciences and medtech companies, healthcare charities and other NHS suppliers, has appointed Paul Rowe as Solution Director for the company’s Investigator XD product.
With more than 25 years’ experience of sales, marketing and training roles within the pharmaceutical industry, Paul will be responsible for the continuous development of Wilmington Healthcare’s Investigator XD platform as he brings together the company’s unrivalled, unique healthcare data and insight solutions into one cloud-based intelligence tool.
Paul is promoted from the role of Head of Sales at Wilmington Healthcare which he has held for nearly three years. Prior to this Paul has successfully held roles at Daiichi Sankyo and Bayer.
Paul says: “This is an exciting time at Wilmington Healthcare as we integrate our unrivalled data sources and information into one healthcare intelligence tool. We know ‘who’s who’ in the new NHS landscape and what their priorities and focus are better than anyone. And through our powerful insights platform we are able to inspire clients to transform their engagement with NHS customers – at a System, Place and Neighbourhood level – while identifying competitor vulnerability.
“We’re offering the capability to access the most powerful 360 degree view of the System all the way through to the individual customer. By truly integrating System objectives and pressure points, medicines management influences, prescribing decisions and patient outcomes, we are enabling the industry to maximise their market access. This rich data source is complemented by detail of the influential stakeholders, key influencers and opinion leaders across the new landscape in addition to the critical data detailing community demographics and social deprivation to help Industry work with NHS customers to tackle health inequalities and improve population health across care pathways.”
Jonathan Carney, Director of Insights and Key Account Management at Wilmington Healthcare, says: “Seismic shifts in the way the NHS is organised is directly impacting the way it will work with the life science and medtech sectors. This demands a rethink by Industry of the traditional key account management model and NHS customer intelligence tools if they wish to successfully engage, through tailored conversations, in this new environment.
“We are delighted that Paul is leading the next phase of our customer intelligence offering as we work with innovation to ensure that clients have the insight and intelligence to transform their relationships with health and social care partners into credible collaborations.”
For more information about Wilmington Healthcare’s insight and intelligence offer, please visit: https://wilmingtonhealthcare.com/what-we-do/healthcare-insight/
Company Details
Latest Content from Wilmington Healthcare
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare
How can pharma engage with key decision-makers in new, collaborative NHS care models?
Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach
HSJ Awards open for entry with promise to champion NHS on its 70th anniversary
HSJ Awards open for entry with promise to champion NHS on its 70th anniversary
Wilmington Healthcare survey finds many doctors fear the NHS will fall victim to another ransomware attack
Following the ransomware attack that wreaked havoc on NHS IT systems last year and resulted in major disruption to patient care, the majority of doctors surveyed by healthcare intelligence provider...
Innovative NHS suppliers scoop HSJ Partnership Awards
Winners include pharma, medtech, healthcare consultants and IT specialists. Innovative pharma and medtech companies have been honoured in an awards scheme run by Health Service Journal (HSJ), the news and...
Managing local population needs is key for the NHS
Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for pharma
Large-scale NHS commissioning models require new partnership approach from pharma
Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working
Leading NHS suppliers highlighted in shortlist for new HSJ awards
The finalists for the first HSJ Healthcare Partnership Awards have been announced. The awards serve to recognise and celebrate those suppliers who work in partnerships with the NHS to drive...
Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS
How can pharma engage with the top performing STPs?
The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...